LMNL News and Press, Liminal Biosciences Inc From 07/12/23

2023-07-12 10:03:23 ET Gainers: Healthcare Triangle ( HCTI ) +183% . Recursion Pharmaceuticals ( RXRX ) +71% . Cadrenal Therapeutics ( CVKD ) +43% . Liminal BioSciences ( LMNL ) +40% . Eloxx Pharmaceuticals ( ELOX ) +29% . L...

Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP Canada NewsWire Liminal BioSciences minority shareholders to receive US$8.50 in cash per share in "go private" transaction LAVAL, QC , CAMBRIDGE, England , and TORONTO , ...

Liminal BioSciences Announces Voting Results of its 2023 Annual General Meeting of Shareholders Canada NewsWire LAVAL, QC and CAMBRIDGE, England , June 5, 2023 /CNW/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company") announced ...

Liminal BioSciences Provides R&D Update Liminal BioSciences Provides R&D Update Canada NewsWire LMNL6326 nominated as lead preclinical candidate for OXER1 antagonist development program, targeting the treatment of eosinophil-driven diseases Ad...

2023-05-09 17:37:00 ET Liminal BioSciences press release ( NASDAQ: LMNL ): Net Loss was C$7.4 million for the first quarter of 2023 compared to income of C$11.2 million for the first quarter of 2022. Cash and cash equivalents were C$26.9 million at March 31, 2023 while our...

Liminal BioSciences Reports First Quarter Financial Results 2023 Canada NewsWire GPR84 antagonist program and OXER1 antagonist program on track to meet previously stated milestones in 2023 Closed March 31, 2023 with just over CAD26.9 million cash on hand, exp...

The Special Committee of the Board of Directors of Liminal Biosciences Retains an Independent Financial Advisor in Response to Unsolicited Non-Binding Transaction Proposal Canada NewsWire LAVAL , QC and CAMBRIDGE, England , May 8, 2023 /CNW/ - ...

2023-04-06 08:23:15 ET Lumentum Holdings ( LITE ) -14% on lowering Q3 expectations. Scilex Holding Company ( SCLX ) -13% a nnounces p ostponement of annual meeting of stockholders. AMC Entertainment Holdings ( APE ) -12% as court rules against c...

Liminal BioSciences Inc. (NASDAQ: LMNL) is one of today's top gainers. The company's shares are currently up 75.13% on the day to $6.62. Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, ...

2023-04-05 10:21:14 ET Nanocap biotech Liminal BioSciences ( NASDAQ: LMNL ) added ~77% in the morning hours Wednesday after announcing an unsolicited non-binding proposal from Structured Alpha LP to obtain the full ownership of the company for $7.50 per share in cash. Stru...